Nevertheless, the rate of SARS-CoV-2 IgM detection (1.48% of patients) in the first month of accrual in asymptomatic neoplastic patients is consistent with the rate of asymptomatic infections diagnosed after massive testing via NPS in particular settings such as Vo’ Euganeo during the peak of the first wave [14]. The gene discussed is CD40LG; the disease is infection.